MAIA与MP-3在健康受试者及糖尿病、糖尿病视网膜病变和年龄相关性黄斑变性患者中的比较
这项横断面研究纳入80名受试者共111只眼(健康眼43只、无糖尿病视网膜病变的糖尿病眼14只、糖尿病视网膜病变眼32只、年龄相关性黄斑变性眼22只),用MAIA和MP-3微视野计以10-2黄斑网格68个刺激点相同参数检测,发现MAIA的平均敏感度始终高于MP-3,MP-3在更多眼检出绝对暗点,健康眼的一致性优于糖尿病视网膜病变眼(P < 0.001)或年龄相关性黄斑变性眼(P = 0.015)。
要点
- MAIA测得的平均敏感度始终高于MP-3。
- MP-3检出绝对暗点的眼数多于MAIA(MAIA 6只眼 vs MP-3 10只眼)。
- 健康眼一致性优于糖尿病视网膜病变眼(P < 0.001)或年龄相关性黄斑变性眼(P = 0.015)。
核心结论
- 两种设备均能有效检测视网膜功能变化和暗点;本研究开发的转换方法有助于跨设备比较,但视网膜病变(糖尿病和年龄相关性黄斑变性)会引入额外的设备间变异。
研究设计与样本
- 横断面研究,纳入80名受试者共111只眼(健康眼43只、无糖尿病视网膜病变的糖尿病眼14只、糖尿病视网膜病变眼32只、年龄相关性黄斑变性眼22只,年龄57.2 ± 20.3岁)。
- 受试者均用MAIA和MP-3两种微视野计检测,采用10-2黄斑网格68个刺激点和相同参数。
- 采用诊断校正的线性回归模型和混合模型将MP-3平均敏感度映射为MAIA平均敏感度,并用Bland-Altman分析评估一致性。
主要发现
- MAIA测得的平均敏感度始终高于MP-3。
- MP-3检出绝对暗点的眼数多于MAIA(MAIA 6只眼 vs MP-3 10只眼)。
- 健康眼的一致性优于糖尿病视网膜病变眼(P < 0.001)或年龄相关性黄斑变性眼(P = 0.015)。
- 将MP-3平均敏感度转换为MAIA平均敏感度后一致性改善、重复性系数(CoR)降低,但未能完全解释设备间变异。
- MP-3判定为固视相对不稳定或不稳定的眼数多于MAIA(P = 0.014)。
关键数值与推荐
- MAIA检出绝对暗点6只眼 vs MP-3检出10只眼。
- 健康眼与糖尿病视网膜病变眼一致性比较P < 0.001,与年龄相关性黄斑变性眼比较P = 0.015。
- MP-3与MAIA固视稳定性分类比较P = 0.014。
临床怎么用
- 原文未据此给出推荐。
局限性
- 视网膜病变(糖尿病和年龄相关性黄斑变性)会引入额外的设备间变异。
- 转换方法未能完全解释设备间变异。
- 作者指出未来纳入多种设备的研究应在研究设计中考虑这种变异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study was to assess the comparability of mean sensitivity (MS) values obtained using the Macular Integrity Assessment (MAIA; CenterVue S.p.A. [iCare], Padova, Italy) and Microperimeter-3 (MP-3; NIDEK CO., Ltd., Gamagori, Japan) microperimetry (MP) devices. METHODS: This cross-sectional study includes subjects with healthy eyes, eyes with diabetes mellitus without diabetic retinopathy (DM no DR), diabetic retinopathy (DR), and non-exudative age-related macular degeneration (AMD). Patients underwent testing on both MAIA and MP-3 MP devices, using a 10-2 macular grid with 68 stimuli and identical parameters. A diagnosis-adjusted linear regression model and mixed modeling mapped MP-3 MS to MAIA MS and Bland-Altman analysis were used to assess the agreement. RESULTS: One hundred eleven eyes (43 healthy eyes, 14 eyes with DM no DR, 32 eyes with DR, and 22 eyes with AMD) from 80 subjects (age = 57.2 ± 20.3 years) were enrolled. MAIA consistently showed higher MS than MP-3. The MP-3 device detected absolute scotomatous points in more eyes than MAIA (6 eyes [MAIA] vs. 10 eyes [MP-3]). Healthy eyes exhibited stronger agreements than those with DR (P < 0.001) or AMD (P = 0.015). Converting MP-3 to MAIA MS improved agreement and reduced coefficients of repeatability (CoRs) but did not fully account for inter-device variability. MP-3 classified more eyes as having relatively unstable or unstable fixation than MAIA (P = 0.014). CONCLUSIONS: Both devices effectively detect retinal functional changes and scotomas. The conversion methods developed in this study can aid cross-device comparisons, but retinal pathologies (DM and AMD) introduce additional inter-device variability. Future studies incorporating multiple devices should account for this variability in their study design.
引用
- Marmalidou A, Siddiqui H, Jamil MU, et al. Comparison Between MAIA and MP-3 In Healthy Subjects and Patients With Diabetes, Diabetic Retinopathy, and Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2025. PMID: 40152761. doi:10.1167/iovs.66.3.59
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。